Health outcome measures | Rotavirus | HPV |
---|---|---|
Target population (year 2010) | 75,761,613 | 32,453,017 |
Number vaccinated | 53,033,129 | 22,717,112 |
Number of lives saved per 1000 vaccinated | 5.2 | 12.6 |
Deaths averted (r = 0%) | 273,855 | 285,921 |
   Deaths averted by region (r = 0%) (% of total) |  |  |
AFR D, E | 148,541 (54%) | 89,524 (31%) |
AMR A, B, D | 1,808 (1%) | 6,651 (2%) |
EMR D | 30,238 (11%) | 12,611 (4%) |
EUR B, C | 3,257 (1%) | 3,554 (1%) |
SEAR B, D | 85,579 (31%) | 161,724 (57%) |
WPR B | 4,432 (2%) | 11,857 (4%) |
Years of life saved (r = 0%) | 15,740,674 | 6,030,585 |
Years of life saved (r = 3%) | 7,121,323 | 1,266,029 |
DALYs averted (r = 0%, uniform age weight) | 15,767,404 | 6,191,573 |
DALYs averted (r = 3%, uniform age weight)* | 7,146,859 | 1,304,426 |
   DALYs averted by region (r = 3%, uniform age-weight) (% of total) |  |  |
AFR D, E | 3,748,499 (52%) | 436,230 (33%) |
AMR A, B, D | 50,093 (1%) | 34,160 (3%) |
EMR D | 784,703 (11%) | 55,724 (4%) |
EUR B, C | 90,541 (1%) | 21,296 (2%) |
SEAR B, D | 2,350,198 (33%) | 707,996 (54%) |
WPR B | 122,825 (2%) | 49,020 (4%) |
DALYs averted (r = 0%, non-uniform age weight) | 18,920,531 | 4,847,082 |
DALYs averted (r = 3%, non-uniform age weight) | 8,121,119 | 1,148,295 |